Gerard J. Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University and Director of the Temple Lung Center, shared his thoughts about ensifentrine, a new bronchodilator treatment currently in development as a potential therapy option for cystic fibrosis, COPD and asthma.